SIDEROBLASTIC ANEMIA

 

SIDEROBLASTIC ANEMIA

 

DEFINITION:

A heterogeneous group of disorders characterized by the ab normal utilization of iron resulting in a microcytic anemia.

EPIDEMIOLOGY:

  • incidence: ?
  • age of onset:
    • childhood
  • risk factors:
    • see below

 

 

PATHOGENESIS:

1. Classification of Sideroblastic Anemias

1. Hereditary

  • 1. X-linked
  • 2. Autosomal Recessive
  • 2. Acquired

  • 1. Idiopathic
  • 2. Secondary
  • 1. Drugs
    • alcohol, chloramphenicol, cytotoxic drugs (aza-thioprine, nitrogen mustard), isoniazid, lead
  • 2. Diseases
  • 1. Hematologic
    • hemolytic anemia, leukemia, megalobastic anemia
  • 2. Inflammatory
    • autoimmune disorders, polyarteritis nodosa, rheumatoid arthritis
  • 3. Neoplastic
    • Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma
  • 2. Pathogenesis

    • in Sideroblastic Anemia, there appears to be an inadequate or abnormal utilization of intracellular iron for hemoglobin synthesis despite adequate or increased amounts of iron within the mitochondria of RBC precursors

    CLINICAL FEATURES:

    1. Anemia

    • mild to severe
    • tends to be mild during childhood becoming more severe and refractory to treatment in adulthood
    • complications
    • 1. Extramedullary Hematopoiesis
      • hepatosplenomegaly (hepatomegaly)
    • 2. Hemosiderosis
    • 1. Cardiomyopathy
      • arrhythmias, congestive heart failure, recurrent pericarditis
    • 2. Gastrointestinal
      • hepatic fibrosis and cirrhosis
    • 3. Endocrinopathies
      • diabetes mellitus; secondary hypopituitarism, hypoparathyroidism, hypothyroidism
    • 4. Cutaneous
      • darkening of the skin due to iron-stimulated melanin production
    •  

    INVESTIGATIONS:

    1. Serum

    1. CBC

    • hypochromic, microcytic anemia

    2. Smear

    • marked anisocytosis and poikilocytosis

    3. Iron Studies

    • elevated serum ferritin
    • elevated serum iron
    • decreased (or normal) transferrin (TIBC)

    2. Bone Marrow

    • erythroid hyperplasia
    • course hemosiderin granules (containing iron), form a peri-nuclear ring within the normoblasts and these cells are called "ringed sideroblasts" - increased in the bone marrow of patients with Sideroblstic Anemia

     

    MANAGEMENT:

    1. Supportive

    • treat underlying disorder if a secondary etiology
    • usually do not respond to iron therapy
    • PRBC transfusions if anemia severe

     

    2. Medical

    1. Pyridoxine (Vitamin B6)

    • 200-500 mg/day
    • some cases are partially responsive

     

     

     

    Pediatric Database - SIDEROBLASTIC ANEMIA

    Pediatric Organization - Pedbase [at] Gmail.com